Caricamento...
Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34(+) cell therapy on VA burden in patients with chronic heart failure (CHF). We performed registry data analysis of patients with C...
Salvato in:
| Pubblicato in: | Cell Transplant |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6719496/ https://ncbi.nlm.nih.gov/pubmed/31046425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0963689719840351 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|